Stock A311690 CJ BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights CJ Bioscience, Inc.

Equities

A311690

KR7311690002

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 04/06/2024 am IST 		5-day change 1st Jan Change
13,900 KRW -1.21% Intraday chart for CJ Bioscience, Inc. -0.50% -13.88%
2023 CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation CI
2023 CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
CJ Bioscience, Inc. agreed to acquire Red BIO business of CJ Cheiljedang Corporation for KRW 6.1 billion.
CI
CJ Cheiljedang Corporation completed the acquisition of 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd..
CI
CJ Cheiljedang Corporation signed a stock purchase contract to acquire 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd. for KRW 25 billion.
CI
ChunLab, Inc. has completed an IPO in the amount of KRW 17.2 billion.
CI
ChunLab Releases Beta Version of TrueBac ID, the Genome-Based Diagnostic Solution for Bacterial Identification
CI
ChunLab, Inc. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A311690 Stock
  4. News CJ Bioscience, Inc.
  5. Highlights